CEPHORUM 250 MG FILM-COATED TABLETS FOR DOGS

מדינה: אירלנד

שפה: אנגלית

מקור: HPRA (Health Products Regulatory Authority)

מרכיב פעיל:

CEFALEXIN (AS CEFALEXIN MONOHYDRATE) PH. EUR

זמין מ:

Forum Products Limited

קוד ATC:

QJ01DB01

INN (שם בינלאומי):

CEFALEXIN (AS CEFALEXIN MONOHYDRATE) PH. EUR

כמות:

250 mg/tablet

טופס פרצבטיות:

Film Coated Tablet

סוג מרשם:

POM

קבוצה תרפויטית:

Canine

איזור תרפויטי:

Cefalexin

סממני תרפויטית:

Antibacterial

מצב אישור:

Authorised

תאריך אישור:

2012-02-24

מאפייני מוצר

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Cephorum 250 mg film-coated tablets for dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
Active ingredient:
Cefalexin 250 mg
(equivalent to cefalexin monohydrate 263 mg)
Excipients:
Titanium dioxide (E171) 0.55 mg
Excipient qsp 1 tablet of 355 mg
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Film-coated tablet.
Round, white to yellowish, biconvex tablet, scored on one side.
‘CX’ is imprinted above the scoreline, ‘250’ is
imprinted below the scoreline.
The tablets are not divisible.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is indicated for the treatment of urinary tract infections
in dogs caused by_ Klebsiella pneumoniae_ and for
the treatment of bacterial skin infections in dogs, when susceptible
organisms are present.
4.3 CONTRAINDICATIONS
Do not use in cases of known hypersensitivity to the active substance,
to other cephalosporins, to other substances of
the
-lactam group or to any of the excipients.
Do not use in rabbits, gerbils, guinea pigs and hamsters.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_3_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_2_
_2_
_8_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
i. Special precautions for use in animals
Use of the pro